Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 1 25-29, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Risk of squamous cell carcinoma of the skin in relation to plasma selenium, alpha-tocopherol, beta-carotene, and retinol: a nested case-control study

MR Karagas, ER Greenberg, D Nierenberg, TA Stukel, JS Morris, MM Stevens and JA Baron
Department of Community and Family Medicine, Dartmouth Medical School, Hanover, New Hampshire 03755-3861, USA.

We conducted a nested case-control study of squamous cell skin cancer (SCC) to determine whether risk was related to plasma concentrations of selenium, alpha-tocopherol, beta-carotene, and retinol. We derived the study sample from participants in our Skin Cancer Prevention Study, all of whom had at least one basal cell or squamous cell skin cancer before study entry. Those who developed a new squamous cell skin cancer during the 3-5-year follow-up period were selected as cases (n = 132). Controls (n = 264) were chosen at random, with matching by age, sex, and study center, from among those who did not develop SCC but were being followed actively at the time the SCC case was diagnosed. Prediagnostic plasma samples were analyzed for alpha-tocopherol, beta-carotene, and retinol using high-performance liquid chromatography. Selenium determinations were made using instrumental neutron activation analysis. Odds ratios were computed using conditional logistic regression for matched samples. We found no consistent pattern of SCC risk associated with any of the nutrients examined. The odds ratios (95% confidence intervals) for the highest versus the lowest quartiles of beta-carotene, retinol, alpha-tocopherol, and selenium were 0.73 (0.38-1.41), 1.43 (0.77-2.64), 0.89 (0.43-1.85), and 0.86 (0.47-1.58), respectively. Thus, our data add to the growing body of evidence that these nutrients, at the concentrations we evaluated, are not related strongly to SCC risk.

This article has been cited by other articles:

				S. Hercberg, K. Ezzedine, C. Guinot, P. Preziosi, P. Galan, S. Bertrais, C. Estaquio, S. Briancon, A. Favier, J. Latreille, et al. Antioxidant Supplementation Increases the Risk of Skin Cancers in Women but Not in Men J. Nutr., September 1, 2007; 137(9): 2098 - 2105. [Abstract] [Full Text] [PDF]

				Y. Chen, M. Hall, J. H. Graziano, V. Slavkovich, A. van Geen, F. Parvez, and H. Ahsan A Prospective Study of Blood Selenium Levels and the Risk of Arsenic-Related Premalignant Skin Lesions Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 207 - 213. [Abstract] [Full Text] [PDF]

				S. A. McNaughton, G. C. Marks, and A. C. Green Role of Dietary Factors in the Development of Basal Cell Cancer and Squamous Cell Cancer of the Skin Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1596 - 1607. [Abstract] [Full Text] [PDF]

				J. F. Dorgan, N. A. Boakye, T. R. Fears, R. L. Schleicher, W. Helsel, C. Anderson, J. Robinson, J. D. Guin, S. Lessin, L. D. Ratnasinghe, et al. Serum Carotenoids and {alpha}-Tocopherol and Risk of Nonmelanoma Skin Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1276 - 1282. [Abstract] [Full Text] [PDF]

				A. J. Duffield-Lillico, E. H. Slate, M. E. Reid, B. W. Turnbull, P. A. Wilkins, G. F. Combs Jr., H. K. Park, E. G. Gross, G. F. Graham, M. S. Stratton, et al. Selenium Supplementation and Secondary Prevention of Nonmelanoma Skin Cancer in a Randomized Trial J Natl Cancer Inst, October 1, 2003; 95(19): 1477 - 1481. [Abstract] [Full Text] [PDF]

				U. M. Frieling, D. A. Schaumberg, T. S. Kupper, J. Muntwyler, and C. H. Hennekens A Randomized, 12-Year Primary-Prevention Trial of Beta Carotene Supplementation for Nonmelanoma Skin Cancer in the Physicians' Health Study Arch Dermatol, February 1, 2000; 136(2): 179 - 184. [Abstract] [Full Text] [PDF]